Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
15.9%
% of BTEC's 220 holdings also in WDNA
38.2%
% of WDNA's 91 holdings also in BTEC
Overlap by Weight
Sector Drift (BTEC minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BTEC |
Weight in WDNA |
Overlap | |
---|---|---|---|---|
NATERA INC | 2.3% | 1.9% | 1.9% | |
BRIDGEBIO PHARMA, INC. | 1.4% | 2.0% | 1.4% | |
BLUEPRINT MEDICINES CORP. | 1.4% | 2.2% | 1.4% | |
IONIS PHARMACEUTICALS, INC. | 1.5% | 1.2% | 1.2% | |
SAREPTA THERAPEUTICS INC | 2.6% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
BTEC Overweight Relative to WDNA
KARUNA THERAPEUTICS, INC. | 2.7% | |
ELANCO ANIMAL HEALTH, INC. | 1.8% | |
CYTOKINETICS INC | 1.7% | |
APELLIS PHARMACEUTICALS, INC. | 1.7% | |
INTRA-CELLULAR THERAPIES INC | 1.6% | |
VAXCYTE, INC. | 1.6% | |
CEREVEL THERAPEUTICS HOLDINGS INC | 1.5% | |
ALNYLAM PHARMACEUTICALS INC | 1.5% | |
SAREPTA THERAPEUTICS INC | 1.4% | |
EXACT SCIENCES CORP | 1.4% |
BTEC Underweight Relative to WDNA
IOVANCE BIOTHERAPEUTICS INC | -2.9% | |
FATE THERAPEUTICS INC | -2.8% | |
TWIST BIOSCIENCE CORP. | -2.7% | |
NOVOZYMES A/S-B SHARES | -2.4% | |
ELI LILLY & CO | -1.9% | |
CRISPR THERAPEUTICS AG | -1.8% | |
CARIBOU BIOSCIENCES, INC. | -1.4% | |
EDITAS MEDICINE, INC. | -1.4% | |
ALCOBRA LTD | -1.4% | |
VERTEX PHARMACEUTICALS INC | -1.3% |